At the Heart of Safe and Successful Pregnancies in Cancer Survivors∗

At the Heart of Safe and Successful Pregnancies in Cancer Survivors∗

Bibliographic Details
Main Authors:	Melissa M. Hudson, MD, Matthew J. Ehrhardt, MD, MS
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	JACC. CardioOncology
Subjects:	cancer survivors cancer therapy-related cardiac dysfunction cardiotoxicity heart failure pregnancy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087320300764

Similar Items

Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy
by: Mark Nolan, MBBS, PhD, et al.
Published: (2020-06-01)

Development and Phenotype of Heart Failure in Long‐Term Survivors of Childhood Cancer: The CVSS Study
by: Sebastian Göbel, et al.
Published: (2023-10-01)

Maternal Cardiovascular Outcomes of Pregnancy in Childhood, Adolescent, and Young Adult Cancer Survivors
by: Neha Bansal, et al.
Published: (2022-10-01)

Cardiac Events in Childhood Cancer Survivors Treated with Anthracyclines: The Value of Previous Myocardial Strain Measurement
by: Milanthy Pourier, et al.
Published: (2022-03-01)

Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
by: Jeannette R. Wong-Siegel, et al.
Published: (2023-07-01)

Cardiological parameters predict mortality and cardiotoxicity in oncological patients
by: Sebastian W. Romann, et al.
Published: (2024-02-01)

High‐sensitivity cardiac troponin T determines all‐cause mortality in cancer patients: a single‐centre cohort study
by: Daniel Finke, et al.
Published: (2021-10-01)

Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study
by: E. A. M. (Lieke) Feijen, et al.
Published: (2019-01-01)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
by: Kara Annette Thompson
Published: (2018-03-01)

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy
by: Anthony F. Yu, MD, et al.
Published: (2020-06-01)

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’
by: Markus S. Anker, et al.
Published: (2019-12-01)

The Impact of Exercise on Cardiotoxicity in Pediatric and Adolescent Cancer Survivors: A Scoping Review
by: Stephanie J. Kendall, et al.
Published: (2022-09-01)

Editorial: Cardiovascular sequelae of chemotherapy and radiotherapy in cancer survivors: current evidence and perspectives
by: Tamara Felici, et al.
Published: (2023-06-01)

A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies
by: Lori Chait-Rubinek, et al.
Published: (2019-07-01)

Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children
by: Mohamed Hegazy, et al.
Published: (2023-01-01)

Anthracycline’s Effects on Heart Rate Variability in Children with Acute Lymphoblastic Leukemia: Early Toxicity Signs—Pilot Study
by: Diana R. Lazar, et al.
Published: (2023-11-01)

Cardiac Disease in Childhood Cancer Survivors
by: Jan M. Leerink, MD, et al.
Published: (2020-09-01)

Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report
by: Hirotaka Suto, et al.
Published: (2023-04-01)

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
by: Ezekowitz Justin, et al.
Published: (2011-07-01)

Hypocalcaemia as a Reversible Cause of Acute Heart Failure in a Long-Term Survivor of Childhood Cancer
by: Inês Almeida Costa, et al.
Published: (2017-10-01)

A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors
by: Nathanya Baez Hernandez, et al.
Published: (2024-04-01)

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
by: Vanesa Gregorietti, et al.
Published: (2020-11-01)

Late laryngeal dysfunction in head and neck cancer survivors
by: Sarah Almas, et al.
Published: (2023-10-01)

Pregnancy rate, maternal and neonatal outcomes among breast cancer survivors: A systematic review
by: Marzieh Azizi, et al.
Published: (2023-10-01)

Heart failure in childhood cancer survivors—a systematic review protocol
by: Tove Berg, et al.
Published: (2022-03-01)

Methamphetamine‐Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities
by: Stephen D. Dickson, et al.
Published: (2021-08-01)

Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study
by: Julius C. Heemelaar, et al.
Published: (2023-02-01)

Heart Disease Mortality in Cancer Survivors: A Population‐Based Study in Japan
by: Yasufumi Gon, et al.
Published: (2023-12-01)

Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study
by: Il Yong Chung, et al.
Published: (2020-10-01)

Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy
by: Janine A. M. Kamphuis, et al.
Published: (2020-10-01)

The Role of Nutrition in Primary and Secondary Prevention of Cardiovascular Damage in Childhood Cancer Survivors
by: Fiorentina Guida, et al.
Published: (2022-08-01)

Automated Global Longitudinal Strain Assessment in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia
by: Rafael Gonzalez-Manzanares, et al.
Published: (2022-03-01)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
by: Victorita Sorodoc, et al.
Published: (2022-08-01)

Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study
by: Gloria Heredia, et al.
Published: (2023-10-01)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
by: Andrew J. Piper-Vallillo, MD, et al.
Published: (2020-03-01)

Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure
by: Marina V. Vitsenya, et al.
Published: (2023-09-01)

Mechanisms and Insights for the Development of Heart Failure Associated with Cancer Therapy
by: Claire Fraley, et al.
Published: (2021-09-01)

Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study
by: Esmee C. M. Kooijmans, et al.
Published: (2022-06-01)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)